- Home
- WOW vs RCKT Comparison
WOW vs RCKT Comparison
Compare WOW & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOW
- RCKT
- Stock Information
- Founded
- WOW 2001
- RCKT 1999
- Country
- WOW United States
- RCKT United States
- Employees
- WOW N/A
- RCKT N/A
- Industry
- WOW Cable & Other Pay Television Services
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- WOW Telecommunications
- RCKT Health Care
- Exchange
- WOW Nasdaq
- RCKT Nasdaq
- Market Cap
- WOW 285.5M
- RCKT 328.6M
- IPO Year
- WOW 2017
- RCKT N/A
- Fundamental
- Price
- WOW $5.09
- RCKT $3.28
- Analyst Decision
- WOW Hold
- RCKT Buy
- Analyst Count
- WOW 2
- RCKT 13
- Target Price
- WOW $5.20
- RCKT $12.96
- AVG Volume (30 Days)
- WOW 3.4M
- RCKT 6.0M
- Earning Date
- WOW 08-11-2025
- RCKT 08-07-2025
- Dividend Yield
- WOW N/A
- RCKT N/A
- EPS Growth
- WOW N/A
- RCKT N/A
- EPS
- WOW N/A
- RCKT N/A
- Revenue
- WOW $604,800,000.00
- RCKT N/A
- Revenue This Year
- WOW N/A
- RCKT N/A
- Revenue Next Year
- WOW N/A
- RCKT $108.43
- P/E Ratio
- WOW N/A
- RCKT N/A
- Revenue Growth
- WOW N/A
- RCKT N/A
- 52 Week Low
- WOW $3.06
- RCKT $2.19
- 52 Week High
- WOW $5.79
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- WOW 77.52
- RCKT 51.17
- Support Level
- WOW $5.06
- RCKT $2.88
- Resistance Level
- WOW $5.12
- RCKT $3.74
- Average True Range (ATR)
- WOW 0.03
- RCKT 0.27
- MACD
- WOW 0.03
- RCKT 0.02
- Stochastic Oscillator
- WOW 70.00
- RCKT 35.43
About WOW WideOpenWest Inc.
WideOpenWest Inc is a cable operator and broadband service, provider. The company serves residential, business and wholesale customers in Illinois, Michigan, Indiana, Ohio, Kansas, Tennessee, Maryland, and South Carolina. Its service portfolio consists of high-speed internet, data, voice, cloud, and cable television services. The company operates in one business segment that is Broadband Services. The majority of the revenue is generated from the subscription service revenue received.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.